HIV incidence and factors contributed to retention in a 12-month follow-up study of injection drug users in Sichuan Province, China

Journal of Acquired Immune Deficiency Syndromes

Volumn 39, Issue 4, 2005, Pages 459-463

  Ruan, Yuhua ^a   Qin, Guangming ^b   Liu, Shizhu ^a   Qian, Hanzhu ^c   Zhang, Li ^a   Zhou, Feng ^a   He, Yixin ^a   Chen, Kanglin ^d   Yin, Lu ^a   Chen, Xianhuang ^d   Hao, Qinlin ^d   Xing, Hui ^a   Song, Yanhui ^a   Wang, Yunxia ^a   Hong, Kunxue ^a   Chen, Jianping ^a   Shao, Yiming ^a  

^a CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^b SICHUAN CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^d Xichang Center for STD and Leprosy Control   (China)

Author keywords

China; HIV 1 subtypes; Incidence; Injection drug users; Prospective cohort study; Retention

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY;

ADULT; ANTIBODY DETECTION; ARTICLE; CHINA; COHORT ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SEROCONVERSION; VIRUS TRANSMISSION;

ADULT; CHINA; COHORT STUDIES; FEMALE; HIV INFECTIONS; HUMANS; INCIDENCE; MALE; PATIENT DROPOUTS; PROSPECTIVE STUDIES; RISK FACTORS; SEXUAL BEHAVIOR; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 22344438447     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.qai.0000152398.47025.0f     Document Type: Article

References (17)

1. China Ministry of Health and United Nations Theme Group on HIV/AIDS in China. A joint assessment of HIV/AIDS prevention, treatment and care in China. China Ministry of Health, Beijing, China; December 1, 2003.
2. Xiao S, Hao W. Young DS. Epidemiological survey on illicit drug use in five high prevalence areas in China. Part I: demographics and prevalence rates. Zhonghua Jing Sheng Wei Sheng Za Zhi. 1996;10:234-238.
3. Hao W, Xiao SY, Liu TQ, et al. The second national epidemiological survey on illicit drug use at six high-prevalence areas in China: prevalence rates and use patterns. Addiction. 2002;87:1305-1315.
4. China Ministry of Public Security. Report of drug user in China. June 25, 2003. Available at: www.mps.gov.cn/webpage/showNews.asp?id=1000& biaoshi=bitGreatNews. Accessed November 1, 2004.
5. MaY, Li ZZ, Zhang KX, et al. Identification of HIV infection among drug users in China. Zhonghua Liu Xing Bing Xue Za Zhi. 1990;11:184-185.
6. Beyrer C, Razak MH, Lisam K, et al. Overland heroin trafficking routes and HIV-1 spread in south and south-east Asia. AIDS. 2000;14:75-83.
7. Zheng XW, Tian CQ, Choi K, et al. Injecting drug use and HIV infection in southwest China. AIDS. 1994;8:1141-1147.
8. Lai S, Liu W, Chen J, et al. Changes in HIV-1 incidence in heroin users in Guangxi Province, China. J Acquir Immune Defic Syndr. 2001;26:365-370.
9. Yang TL, Xu YC, Hu XH, et al. The prevalence of HIV, HBC and HCV among drug users in Xichang county of Sichuan province, China. Yu Fang Yi Xue He Chuan Ran Bing Xue Za Zhi. 2001;17:170-171.
10. Ruan YH, Chen KL, Hong KX, et al. Community-based survey of HIV transmission modes among injection drug users in Sichuan, China. Sex Transm Dis. 2004;31:623-627.
11. Antoine M, Helen N, Annet DV et al. Sociodemographic and behavioral characteristics associated with timeliness and retention in a 6-month follow-up study of high-risk injection drug users. Am J Epidemiol. 2003;157:930-939.
12. Cottler LB, Compton WM, Ben-Abdallah A, et al. Achieving a 96.6 percent follow-up rate in a longitudinal study of drug abusers. Drug Alcohol Depend. 1996;41:209-217.
13. Baldwin JA, Bowen AM, Trotter RT II. Factors contributing to retention of not-in-treatment drug users in an HIV/AIDS Outreach Prevention Project. Drugs Soc. 1996;9:19-35.
14. Des Jarlais DC, Marmor M, Friedmann P, et al. HIV incidence among injection drug users in New York City, 1992-1997: evidence for a declining epidemic. Am J Public Health. 2000;90:352-359.
15. NIMH Multisite HIV Prevention Trial. Screening, recruiting and predicting retention of participants in a multisite HIV prevention trial. AIDS. 1997;11(Suppl):S13-S19.
16. Shao YM, Su L, Sun XH, et al. Molecular epidemiology of HIV infections in China. Presented at: Fourth International Congress on AIDS in Asia and the Pacific; 1997; Manila.
17. Shao YM, Su L, Zhao F, et al. Genetic recombination of HIV-1 strains identified in China [oral presentation, W A35:429]. Presented at: 12th World Conference on AIDS; Geneva; 1998.